ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

HASSAN HONAINY MD

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,818Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 168

$603K Total Retail Price of All Prescriptions

Rank: 14 out of 168

297 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 297 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

14% of this provider’s 297 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 3,206 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$104 was the average price of a prescription from this provider, compared to $114 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 296 197 1 2
HYDROCODONE-ACETAMINOPHEN 210 77 S3 2 18
LISINOPRIL 209 104 3 3
AMLODIPINE BESYLATE 207 122 4 1
SIMVASTATIN 199 123 5 8
METOPROLOL TARTRATE 194 111 6 7
LEVOTHYROXINE SODIUM 157 90 7 15
RENVELA 149 61 8 4
PROSOL 120 41 9 22
SENSIPAR 115 59 10 5
ALLOPURINOL 107 52 11 13
CLONIDINE HCL 106 31 12 9
LIDOCAINE-PRILOCAINE 96 86 13 94
LOSARTAN POTASSIUM 92 67 14 10
CALCITRIOL 88 77 15 6
SPIRONOLACTONE 84 49 16 25
WARFARIN SODIUM 81 44 17 31
RANITIDINE HCL 78 29 18 51
CIPROFLOXACIN HCL 76 43 19 63
GABAPENTIN 76 46 19 26
OMEPRAZOLE 75 60 21 12
HYDRALAZINE HCL 74 47 22 14
ISOSORBIDE MONONITRATE ER 71 53 23 50
NEXIUM 70 47 24 43
CYCLOBENZAPRINE HCL 68 25 R 25 67
CEPHALEXIN 64 41 26 91
CARVEDILOL 63 31 27 11
GLIMEPIRIDE 61 37 28 44
SERTRALINE HCL 58 23 29 52
LANTUS 56 12 30 37
DIGOXIN 55 19 31 79
METFORMIN HCL 55 38 31 29
GLIPIZIDE 53 29 33 45
METOPROLOL SUCCINATE 51 28 34 16
INSULIN SYRINGE 50 35 35 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.